Package 70121-1463-2

{"route": ["INTRAMUSCULAR"], "spl_id": "84f58921-6fc9-4f8c-b074-a716239e52e2", "openfda": {"nui": ["N0000175582", "N0000000145", "N0000000168"], "unii": ["22X328QOC4"], "rxcui": ["727762"], "spl_set_id": ["f36f19ad-f044-4dba-80b6-d074ddffcd86"], "pharm_class_epc": ["Estrogen Receptor Antagonist [EPC]"], "pharm_class_moa": ["Estrogen Receptor Antagonists [MoA]", "Selective Estrogen Receptor Modulators [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE, GLASS in 1 CARTON (70121-1463-2)  / 5 mL in 1 SYRINGE, GLASS (70121-1463-3)", "package_ndc": "70121-1463-2", "marketing_start_date": "20190304"}], "brand_name": "Fulvestrant", "product_id": "70121-1463_84f58921-6fc9-4f8c-b074-a716239e52e2", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Estrogen Receptor Antagonist [EPC]", "Estrogen Receptor Antagonists [MoA]", "Selective Estrogen Receptor Modulators [MoA]"], "product_ndc": "70121-1463", "generic_name": "Fulvestrant", "labeler_name": "Amneal Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fulvestrant", "active_ingredients": [{"name": "FULVESTRANT", "strength": "250 mg/5mL"}], "application_number": "ANDA210044", "marketing_category": "ANDA", "marketing_start_date": "20190304", "listing_expiration_date": "20261231"}